Elanco Aqua
Elanco Aqua, operating within MSD Animal Health (Merck & Co.), manufactures vaccines, parasiticides, nutritional products, water-treatment solutions, biosecurity agents, and digital traceability technology for commercial aquaculture producers raising salmon, trout, tilapia, barramundi, and shrimp across 60+ countries.
- Company typePublic
- Founded1984
- HeadquartersGreenfield, United States
- Headcount5,001–10,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Elanco Aqua does
Elanco Aqua (operating within MSD Animal Health, a division of Merck & Co., Inc.) manufactures and sells biopharmaceutical and technology products for commercial aquaculture producers worldwide. The product portfolio spans vaccine platforms (inactivated, live, and DNA constructs delivered via injectable, immersion, and oral routes), marine ectoparasite/sea-lice control solutions, shrimp-focused nutritional packages, water-treatment chemistry, disinfectants and biosecurity agents, and a digital technology layer covering animal identification, tracking, traceability, vision systems, and smart counters/graders.
The business serves enterprise commercial aquaculture operators across cold-water (Atlantic salmon, coho, trout), warm-water (tilapia), and marine (barramundi, shrimp) species, with explicit disease-prevention, ectoparasite-management, water-quality, and biosecurity use cases. Technology differentiators highlighted in source material include multiple vaccine platform types, domain-specialized sea-lice control, configurable nutritional packages, and integrated digital traceability/vision tools.
Revenue mechanics are direct enterprise sales conducted through MSD Animal Health's regional country operations spanning more than 60 countries across six macro-regions; pricing is quote-based and not publicly disclosed. The product offering is bundled — vaccines, parasiticides, nutrition, biosecurity, and digital tools are sold under a single vendor relationship, implying a strategy of share-of-wallet expansion within large aquaculture operators rather than point-product transactions. Customer segmentation is horizontal (by species/producer type), and the GTM motion is field-led enterprise sales with regional contact centers rather than self-serve or transactional channels.
Elanco Aqua firmographics
Firmographics- Name
- Elanco Aqua
- Legal name
- MSD Animal Health (operating name of Merck & Co., Inc.)
- Website
- https://elancoaquaglobal.com
- Company type
- Public
- Founded year
- 1984
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- Elanco Aqua, operating within MSD Animal Health (Merck & Co.), manufactures vaccines, parasiticides, nutritional products, water-treatment solutions, biosecurity agents, and digital traceability technology for commercial aquaculture producers raising salmon, trout, tilapia, barramundi, and shrimp across 60+ countries.
- Ownership category
- akta.pro rank
Elanco Aqua industry classification
Industry- Product category
- Animal Health Pharmaceuticals
- NAICS
- Aquaculture (1125), Animal Production and Aquaculture (112), Animal Food Manufacturing (3111)
- SIC
- Agricultural Prod-Livestock & Animal Specialties (200), Food And Kindred Products (2000)
- akta.pro industry
- Aquaculture/Fish & Shrimp VaccinesAquaculture Health, Biosecurity & Veterinary ServicesAgriculture & Food Production/Animal Production & Aquaculture/Aquaculture (Fish & Shellfish Farming)Aquaculture & Fish Health ServicesAquaculture Farm Services & Operations Support (net cleaning, diving, grading, harvesting)Agriculture & Food Production/Animal Production & Aquaculture/Aquaculture (Fish & Shellfish Farming)
Keywords
Where Elanco Aqua is headquartered
LocationHeadquarters
- HQ city
- Greenfield
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Elanco Aqua business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales
Revenue model
- Biopharmaceutical Products: Sale of vaccines, parasiticides, nutritional products, disinfectants, and water treatment solutions to aquaculture producers
- Technology Solutions: Digital tools and technology platforms for aquaculture operations including identification, tracking, traceability, vision technology, and smart counting/grading equipment
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Elanco Aqua product offering
Product offeringCore offering
Elanco Aqua manufactures and supplies biopharmaceutical products and digital technology solutions for commercial aquaculture producers. Its portfolio includes vaccine platforms (inactivated, live, and DNA vaccines) for aquatic species such as salmon, trout, tilapia, barramundi, and shrimp, marine ectoparasite (sea lice) control solutions, shrimp nutritional and water treatment products, biosecurity disinfectants, and digital tools (identification, tracking, traceability, vision technology, smart counters and graders) for farm operations management.
Product overview
MSD Animal Health Aqua division offers a comprehensive biopharmaceutical and technology solutions portfolio for aquaculture producers. The product suite includes: (1) Vaccine platforms for disease prevention in cold water species (Atlantic Salmon, Coho Salmon, Trout), warm water species (Tilapia), and marine species (Barramundi, Shrimp) — available as inactivated, live, and DNA vaccines with injectable, immersion, and oral administration methods; (2) Marine ectoparasite control solutions for sea lice management; (3) Nutritional products and water treatment solutions optimized for shrimp growth and pond conditions; (4) Disinfectants and biosecurity solutions for farm pathogen control; and (5) Technology solutions encompassing identification, tracking, traceability, vision technology, and smart counters and graders for holistic aquaculture operations management.
Differentiator
Problem solved
Functional benefit
Products and services
- Vaccine Platforms (Inactivated, Live, DNA Vaccines) Comprehensive portfolio of vaccine platforms including inactivated, live, and DNA vaccines for various aquatic species including salmon and trout, with multiple administration methods such as injectable, immersion, and oral vaccines. Targeted at commercial aquaculture producers seeking disease prevention solutions.
- Marine Ectoparasite Control Solutions Solutions designed to control sea lice outbreaks and help aquaculture producers maintain healthy and profitable fish farming operations. Targeted at marine aquaculture producers, particularly salmon and barramundi operations.
- Shrimp Nutritional Products Broad portfolio of nutritional products that strengthen shrimp immunity and overall performance, offering tailored packages to optimize growth, health, and sustainability across the lifecycle. Targeted at commercial shrimp producers.
- Water Treatment Solutions Portfolio of water treatment solutions designed to support optimal pond conditions, helping producers maintain healthy environments for shrimp growth. Targeted at warm-water aquaculture producers, including shrimp and tilapia operations.
- Disinfectants and Biosecurity Solutions Range of disinfectants and biosecurity solutions to help aquaculture producers reduce the risk of pathogens entering or spreading within farms. Targeted at commercial aquaculture operations across species.
- Technology Solutions (Identification, Tracking, Traceability) Digital tools enabling aquaculture producers and conservationists to take a holistic approach to managing operations, including identification, tracking, traceability, vision technology, and smart counters and graders for informed decision-making and better animal welfare.
Companies that use Elanco Aqua
Customer profileNamed customers6 records
Segments1 record
Ideal customer profiles1 record
Elanco Aqua technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Elanco Aqua partnerships and signals
Strategic signalScale indicators2 records
Recent moves5 records
Expansion highlights4 records
Elanco Aqua competitors and assessment
Company assessmentBroad incumbents
- Virbac: Independent global animal-health company with vaccines and pharmaceuticals across species including aquaculture. Comparable in scale of animal-health offerings and species breadth, though aquaculture is a smaller slice of Virbac's portfolio.
- Phibro Animal Health: Animal-health and nutrition company with vaccines, parasiticides, and nutritional specialty products serving aquaculture and livestock. Comparable in selling health and nutrition solutions into aquaculture producers, though smaller and more regionally focused.
- Zoetis: Largest global animal-health company, offering vaccines, parasiticides, and diagnostics across livestock, companion animals, and aquaculture. Overlaps with the Aqua division on biopharmaceutical platforms and species coverage but competes through a far broader portfolio.
Direct peers
- Ceva Santé Animale: Global veterinary biopharmaceutical company with a meaningful aquaculture portfolio (vaccines for salmon and shrimp). Most directly comparable in product mix and species focus among privately held peers.
- Elanco Animal Health: Pure-play animal-health company (now part of Merck Animal Health) that historically operated an aquaculture health franchise including vaccines and water-treatment products. Most directly comparable to the named 'Elanco Aqua' entity in the source data.
- Benchmark Holdings: Aquaculture-focused company providing genetics, health, and nutrition products to fish and shrimp producers. Directly comparable in target customer and species scope, with overlapping health and nutrition product lines.
Emerging players
- Skretting (Nutreco): Global aquaculture feed manufacturer (part of Nutreco/Shengmu) supplying nutritional products to salmon, shrimp, and warm-water fish producers. Overlaps with the Aqua division's nutritional-products portfolio and shares the same customer base.
- BioMar: Major aquaculture feed producer serving salmon, trout, shrimp, and other species worldwide. Comparable customer base and overlapping value proposition in shrimp and salmon nutritional and health-supporting products.
- Alltech: Animal nutrition and health company with a significant aquaculture portfolio spanning feed additives, probiotics, and health-supporting solutions. Comparable in selling into aquaculture producers with health-and-nutrition bundled offerings.
Regional players
- AquaBounty Technologies: Aquaculture-biotech company focused on genetically improved salmon and tilapia, with health-management implications for farmed aquaculture producers. Less direct overlap but adjacent in the aquaculture health and productivity value chain.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Elanco Aqua social profiles
Digital presenceElanco Aqua financial estimates
Financial estimateRevenue estimate
Valuation estimate
Elanco Aqua leadership team
Management profileNumber of profiles
Elanco Aqua funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Elanco Aqua M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Elanco Aqua
What does Elanco Aqua do?
Elanco Aqua manufactures and supplies biopharmaceutical products and digital technology solutions for commercial aquaculture producers. Its portfolio includes vaccine platforms (inactivated, live, and DNA vaccines) for aquatic species such as salmon, trout, tilapia, barramundi, and shrimp, marine ectoparasite (sea lice) control solutions, shrimp nutritional and water treatment products, biosecurity disinfectants, and digital tools (identification, tracking, traceability, vision technology, smart counters and graders) for farm operations management.
Is Elanco Aqua a public or private company?
Elanco Aqua is a public company. It is classified as unknown and is currently operating.
When was Elanco Aqua founded?
Elanco Aqua was founded in 1984. It employs 5,001 to 10,000 people.
Where is Elanco Aqua based?
Elanco Aqua is headquartered in Greenfield, United States, in the North America region.
How does Elanco Aqua make money?
Two revenue lines are on record. Biopharmaceutical Products are the primary driver. The others are technology Solutions.
Who are Elanco Aqua's main competitors?
Broad incumbents on record are Virbac, Phibro Animal Health and Zoetis. Direct peers are Ceva Santé Animale, Elanco Animal Health and Benchmark Holdings. Emerging players are Skretting (Nutreco), BioMar and Alltech. AquaBounty Technologies is listed as a regional player.
Does Elanco Aqua have an API?
No public API is recorded for Elanco Aqua.
What industry is Elanco Aqua in?
Elanco Aqua's product category is Animal Health Pharmaceuticals. Its primary akta.pro industry code is HLAMAKAE, Aquaculture/Fish & Shrimp Vaccines, with a secondary code of AFAEAAAK, Aquaculture Health, Biosecurity & Veterinary Services. Its NAICS code is 1125 and its SIC code is 200.